Trimeris, Vivus may stay active Tuesday evening

Trimeris may see more action late Tuesday following sharp regular-session declines, as the biopharmaceutical company's merger plans fell apart.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.